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The streptogramin A antibiotics have proven to be highly active against Gram 
positive bacteria, particularly methicillin-resistant Staphylococcus aureus. 
Members of this group of compounds are characterized by a 23-membered 
macrocycles containing polyene, oxazole, amide and ester functionality. The 
chemistry and biology of these valuable antimicrobial agents is covered. 
 
1. Introduction 
 
The increased use of antibiotics has led to the occurrence of 
multidrug resistant strains. In particular, the emergence of methicillin-
resistant Staphylococcus aureus (MRSA) is recognized as a serious 
problem. Recently, up to 18% of all infections in European Intensive 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Mini-Reviews in Organic Chemistry, Vol. 4, No. 2 (2007): pg. 159-181. DOI. This article is © Bentham Science Publishers 
and permission has been granted for this version to appear in e-Publications@Marquette. Bentham Science Publishers 
does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express 
permission from Bentham Science Publishers. 
2 
 
Care Units were attributed to oxacillin or methicillin resistant S. aureus 
[1]. These infections include skin and skin structure infections, 
nosocomial pneumonia infections, and catheter related infections. 
Nearly 60% of the ICU acquired S. aureus infections were reported to 
be MRSA [2]. Patients with MRSA infections are linked to increased risk 
of mortality (greater than twice as many deaths “on ward”) and 
prolonged hospitalization (ca. twice as long) compared to patients with 
methicillin susceptible S. aureus [3]. Certain risk factors are associated 
with the development of MRSA infections, including previous antibiotic 
use, prolonged hospitalization, severe underlying disease, old age and 
multiple invasive procedures [4]. Not only is there a human toll, but 
also an increased financial burden associated with these infections [5]. 
Thus, there is clearly the need for antibiotics effective against such 
resistant pathogens. One such class of agents is the streptogramin 
antibiotics. The streptogramin antibiotics, isolated from several species 
of Streptomyces, may be classified into one of two subgroups. One 
subgroup is peptidic in nature and is known as group B, while the 
group A compounds are characterized by a 23-membered macrocyclic 
ring, an oxazole ring, and a conjugated dienyl amine. This review will 
primarily deal with the chemistry and biology of the group A 
streptogramin antibiotics. 
 
2. Biology of Streptogramin A Antibiotics 
 
2.1 Isolation and Structural Assignment 
 
The early literature of the type A streptogramin antibiotics can 
be somewhat confusing due to the different names which were given 
for these compounds by different research groups. For example, the 
isolation of two group A streptogramin antibiotics from Streptomyces 
osteogrycin (originally termed osteogrycins A and G) was reported in 
1958 [6]. These were assigned the structures 1 and 2 (Fig. 1) by Todd 
and co-workers in 1966 on the basis of chemical degradation, and 
NMR spectroscopy and mass spectrometry [7]. A crystal structure of 1 
eventually corroborated the spectroscopy-based assignment [8]. 
Compound 1 was also isolated from Streptomyces olivaceus ATCC 
12019 [9a] (termed PA114A), from Streptomyces mitakaensis [9b] 
(termed mikamycin A], from Streptomyces liodensis ATCC 11415 [9c] 
(termed vernamycin A), from Streptomyces pristinaespiralis [9d] 
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(termed pristinamycin IIA), and from Micromonospora sp. SC 12,650 
[9e] (referred to as vernamycin A). Compounds 1 and 2 are now most 
frequently identified as virginiamycin M1 and M2 respectively. 
 
A structurally related streptogramin antibiotic was isolated from 
Actinomadura flava and several species of Actinoplanes, and its 
structural assignment was reported as 3 (Fig. 1) by several groups 
during the period 1975-79 [10]. This compound is most commonly 
known as madumycin II, however different groups have variously 
referred to 3 as A2314A, A15104V, A17002F, and CP-35,763. The 
structure of 3 differs from the virginiamycins in that the 
proline/dihydroproline group is replaced by a D-alanine unit. 
 
Griseoviridin is a broad spectrum antibiotic isolated from 
Streptomyces griseus [11]. Extensive degradation studies as well as IR 
and UV spectroscopic analysis led to two proposed structures 4 and 5 
for griseoviridin (Fig. 2), with the former being originally favored [12]. 
Eventually, the structure of griseoviridin was reassigned as 5 on the 
basis of X-ray diffraction analysis [13], although one of these 
references incorrectly assigned the relative stereochemistry for the 
C18- C20 diol as trans. The correct stereochemistry of this group is 
cis- as is indicated in structure 5 [13]. Since the configuration at C5 
was known from degradation studies, this allowed for the complete 
stereochemical assignment. More recently, the macrolide conformation 
of griseoviridin in d6-DMSO solution was determined on the basis of 2-
D NMR spectroscopy and restrained molecular dynamics calculations 
[14]. The solution structure is similar to that in the crystal state with 
minor variations in the diendiol segment. 
 
2.2 Biosynthetic Pathways 
 
2.2.1 Biosynthesis of Virginiamycin M1 
 
Kingston’s group has investigated the biosynthetic origin of 
virginiamycin M1 (1) based on incorporation of 13C and 14C labeled 
precursors into the antibiotic produced by Streptomyces virginiae 
strain PDT 30 (Fig. 3) [15]. The antibiotic produced in the presence of 
[1-13C] acetate exhibited enrichment at C5, C7, C12, C14, C16, and 
C18, while 1 produced in the presence of [2-13C] acetate exhibited 
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enrichment at C4, C6, C11, C13, C15, C17, as well as at C33. Notably, 
growth of the microorganism fed with [1,2-13C2] acetate afforded 
virginiamycin M1 which exhibited 13C-13C couplings between C4 and C5, 
C6 and C7, C11 and C12, C13 and C14, C15 and C16, and C17 and 
C18. Notably, there was no coupling between C12 and C33. 
 
The most likely route for introduction of the C33 methyl group 
involves aldol condensation of an individual acetate unit (presumably 
in the form of malonyl CoA), followed by decarboxylation and 
dehydration (Scheme 1).  
 
Growth of S. virginiae in the presence of racemic [3-13C] serine, 
produced 1 which was significantly enriched (ca. 7%) at the C20 
oxazole carbon, indicative of the origin of this ring. Enrichment was 
also observed at the methyl groups C32 and C33. It was proposed that 
enrichment at C33 results from conversion of serine into acetyl CoA via 
pyruvate, while enrichment at C32 results from methyl transfer to 
methionine. To this end, microbial production of the antibiotic in the 
presence of racemic [Me-13C] methionine resulted in enrichment at 
C32. 
 
Feeding [1-13C] glycine to S. virginiae resulted in 1 which was 
enriched at C10 and C22. This is consistent with the N8-C9- C10 
segment arising from glycine. Isotopic labeling at C22 is due to 
conversion of glycine to serine by N5,N10-methylenetetrahydrofolate 
and serine hydroxymethylenetransferase. Microbial production of 1 in 
the presence of racemic [2-13C] valine exhibited significant 13C 
enrichment only at C3. 
 
Finally, growth of S. virginiae in the presence of radiolabeled 
proline (L-[3,4-3H2] proline or L-[U-14C] proline) indicated that this 
amino acid was responsible for the N23-C1 dehydroproline segment. 
 
2.2.2. Biosynthesis of Madumycin II 
 
LeFevre and Kingston have elucidated the biosynthetic origin of 
madumycin II (produced by Actinoplanes philippinensis) using 13C and 
2H labeled precursors [16]. By analogy to the biosynthesis of 
virginiamycin M2 (vide supra), the C4-C7 and C10-C18 chains are 
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likely derived from acetate. Evidence in support of this was obtained in 
the 13C NMR spectra of madumycin II generated in the presence of 
[1,2-13C2] acetate (Fig. 4). Unfortunately, signal overlap for C11, C12, 
and C13 did not allow for either detection of 13C enrichment or 13C-13C 
couplings. As with virginiamycin, microbial production of madumycin II 
in the presence of racemic [2-13C] valine exhibited significant 13C 
enrichment only at C3. 
 
Madumycin II produced in the presence of racemic [1,2,3-13C3] 
serine exhibited 13C enrichment at the oxazole carbons C20, C21, C22, 
the dienyl amine carbons C9 and C10, and at the exocyclic methyl 
C30. Labeling at C9 and C10 arises due to interconversion of serine 
and glycine (vide supra), while labeling at C30 presumably arises via 
conversion of the labeled serine into methionine, followed by 
incorporation. Notably, the madumycin produced under these 
conditions did not exhibit any significant 13C enrichment at the C1, 
C24, or C25 carbons of the alanine segment, thus indicating that the 
biological origin of this segment is not from serine. 
 
The biosynthetic origin of the D-alanine segment (N23,C24,C1) 
was examined by feeding A. philippinensis with doubly labeled L-
alanine (L-[3-13C,3,3,3-2H3] alanine). The madumycin thus produced 
exhibited both 13C and three 2H labels present. Since no 2H isotopic 
label was lost, the intermediacy of dehydroalanine or 24,25-
dehydromadumycin could be ruled out. Furthermore, competitive 
incorporation of labeled L- and D-alanine indicated that there was no 
preference for incorporation of either enantiomer of this amino acid. 
This suggests the occurrence of a facile alanine racemase system, 
which is operative prior to incorporation of D-alanine into the 
madumycin skeleton. 
 
2.3 Mode of Action 
 
Both streptogramin type A and type B antibiotics inhibit protein 
synthesis in Gram-positive bacteria [17]. Bacterial ribosomes are 
comprised of a 50S and 30S subunit, which join into a 70S particle as 
the initiation step for protein synthesis. The sequence of steps in 
protein synthesis involve positioning of an amino acyl-tRNA (at the A 
site of the ribosome) and a peptidyl-tRNA (at the P site). Peptide bond 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Mini-Reviews in Organic Chemistry, Vol. 4, No. 2 (2007): pg. 159-181. DOI. This article is © Bentham Science Publishers 
and permission has been granted for this version to appear in e-Publications@Marquette. Bentham Science Publishers 
does not grant permission for this article to be further copied/distributed or hosted elsewhere without the express 
permission from Bentham Science Publishers. 
6 
 
formation between the NH2 of the amino acyl-tRNA and the CO2H of 
the peptidyltRNA is catalyzed by the peptidyl transferase center (PTC) 
of the 50S ribosome, resulting in formation of an elongated chain at 
the A site. The final step is for translocation of the elongated chain 
from the A site to the P site in order for the process to occur again. 
 
Type A streptogramins block the positioning of both amino acyl-
tRNA at the A site and peptidyl-tRNA at the P site of the ribosome 
[18]. However, while type A streptogramins can bind either the 50S 
subunit, or the assembled 70S ribosome, it can not bind to ribosomes 
already engaged in protein synthesis [19]. It is believed that these 
polyene macrolides bind only to the free arms of peptidyl transferase. 
Binding of streptogramin A antibiotics is believed to cause a 
conformational change in the 50S subunit [20]. To this end, in vitro 
incubation of the 50S subunit with virginiamycin M produced inactive 
particles, even at substoichiometric quantities of the antibiotic. 
Removal of virginiamycin M from these inactivated 50S particles by 
column chromatography did not restore the activity. 
 
Recently the crystal structure of virginiamycin M1 bound to the 
50S ribosome of Haloarcula marismortui was reported (Fig. 5) [21]. 
The structure was solved to the 3.0 Å level; the location, orientation, 
and conformation of 1 in the bound form was unambiguous in the 
difference electron density map. The C14 hydroxyl is hydrogen-bonded 
to the phosphate of A2538, the oxazole ring is positioned in a 
hydrophobic pocket of the A site, with the remainder of 1 extending 
over the ribosome P site. The most notable structural change upon 
binding of 1 is that the conjugated amide functionality (C5-C7) 
occupies an area which is originally populated by the nitrogen base of 
adenosine 2103 in the native structure. This nitrogen base is rotated 
ca. 90o with respect to its original position, and the plane of the 
aromatic base is positioned such that it is parallel to the C5-C6 olefin. 
The amide carbonyl is also hydrogen-bonded to the 2’ hydroxyl of 
A2103. 
 
The crystal structure of 1 bound to the protein Vat(D), a 
streptogramin A acetyltransferase from a human urinary isolate of E. 
faecium, exhibits essentially the same conformation of the macrolide 
ring [22]. This type of enzyme mediates acetylation of the C14 
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hydroxyl of streptogramin A antibiotics, and is linked to acquired drug 
resistance in S. aureus due to drug efflux. In comparison, unbound 1 
adopts a different macrolide conformation in its crystal state (as 
evidenced by X-ray structure) [8], or in CDCl3, CD3OD, or d6-DMSO 
solution, as determined by 2D NMR spectroscopy [23]. The solution 
structures are more compact compared to those observed for bound 1. 
 
Type B streptogramins inhibit protein synthesis by blocking 
peptide bond synthesis [24]. These compounds interact with 
ribosomes actively engaged in protein synthesis indicating that the 
type B streptogramins bind to a portion of the PTC area distinct from 
the A or P sites or the catalytic site. Thus the type A and B 
streptogramin antibiotics inhibit different stages of the protein 
synthesis sequence. Furthermore, the action of the two streptogramin 
types is synergic. Notably, streptogramin B depsipeptides can be 
displaced from the ribosomal complex by the erythromycin antibiotics. 
However, in the presence of a type A streptogramin, this displacement 
of the depsipeptide is not observed (i.e. tighter binding than 
erythromycin). This increase in affinity for the type B streptogramin, in 
the presence of a type A, is attributed to the conformational change in 
the 50S subunit due to type A binding [25]. 
 
Utilization of the interaction between type A and type B 
streptogramin antibiotics culminated in formulation of an injectible 
mixture of two semi-synthetic streptogramin antibiotics, quinupristin 
and daflopristin (3:7), approved by the FDA in 1999 and marketed 
under the name “Synercid” by Aventis Pharmaceuticals (Fig. 6)[26]. 
Synercid is active against gram positive bacteria including vancomycin 
resistant Enterococcus faecium (VREF) and methicillin-susceptible 
Staphylococcus aureus (MSSA), however it is not active against E. 
faecalis. This synergic interaction between type A and type B 
streptogram antibiotics may have additional benefits, since bacteria 
must develop resistance to the action of both type A and B inhibition. 
 
In spite this synergic action, there are cases of quinopristin-
daflopristin resistant E. faecium, isolated from farm animal sources, 
reported in both the USA and Europe [27]. This may be due to the FDA 
approved use of Virginiamycin [a mixture of virginiamycin M and 
virginiamycin S (a streptogramin type B similar to quinopristin)] in 
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chickens, turkeys, swine and cattle for weight gain. However a 
causative relationship between the use of Virginiamycin in animals and 
resistant strains in humans could not be definitively established due to 
the lack of an animal control group for comparison (i.e. animal 
populations not given Virginiamycin). Limiting the use of streptogramin 
antibiotics has been recommended [28] and Denmark has banned the 
use of Virginiamycin as a growth-promoting agent. 
 
3. Syntheses of Streptogramins A 
 
3.1 Syntheses/Synthetic Studies of Virginiamycin M2 
 
3.1.1 Schlessinger/Li Synthesis of Virginiamycin M2 
 
Schlessinger and Li were the first to report a synthesis of 
virginiamycin M2 (2) [29]. Their retrosynthetic strategy (Scheme 2) 
dissected the target molecule into a C3-C7 enal (6), a C9-C16 
dienylamine (7), and a metallated 2,4-oxazole (8). This strategy relied 
on condensations of the anion derived from vinylogous urethanes to 
set the C3 and C14 carbinol stereocenters.  
 
Condensation of 9 with the pyrrolidine 10 (from L-proline) 
followed by methylation gave the vinylogous urethane lactone 11 
(Scheme 3). Deprotonation of 11 followed by reaction with isopropyl 
2-bromoacetate gave a single substituted lactone 12 by alkylation on 
the less hindered face. Reduction of the isopropyl ester, subsequent 
protection of the 1° alcohol and Li metal reduction of the unsaturated 
lactone gave the lactol 13. Oxidative elimination of the pyrrolidine 
from 13 afforded the enal 14, which was protected at the t-BuPh2Si 
ether (15). Horner- Emmons olefination gave the E,E-dienyl nitrile 16 
which upon reduction with alane gave the dienyl amine 17. 
 
Preparation of the C3-C7 enal began with the vinylogous 
urethane 18 (Scheme 4). Aldol condensation of 18 with 
isobutyraldehyde proceeded with erythro selectivity and the resultant 
alcohol condensed on the ester to afford the unsaturated lactone 19 
with 96% de. Dissolving metal reduction of 19 gave the lactol 20 
which upon oxidative elimination of the pyrrolidine generated the 
moderately stable enal 6. 
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Coupling of the C3-C7 hydroxy enal 6 with N-Troc protected D-
proline afforded the ester 21 (Scheme 5). Oxidation of the aldehyde 
functionality with NaClO2 gave the corresponding carboxylic acid. 
Condensation of acid 22 with the dienyl amine 17 under Mukiayama 
conditions [30] generated the amide 23. Selective cleavage of the 1° 
TBS ether in the presence of the 2° BPS ether, followed by oxidation 
gave the aldehyde 24. Addition of the organozinc reagent [31] from 2-
bromomethyl-1,3-oxazole 25 with aldehyde 24 gave 2o alcohol 26 as 
a mixture of diastereomers which were protected as their triethylsilyl 
ethers 27. Reductive removal of the Troc protecting group and 
hydrolysis of the oxazole methyl ester set the stage for a Mukiayama 
macrolactamization to generate cyclic amide 28. Deprotection of the 
TES ether under mild acid conditions, Dess-Martin periodinane 
oxidation, and finally removal of the BPS with HF-pyridine completed 
the synthesis of virginiamycin M2. The synthesis proceeded in 22 
steps, 2.8% overall yield from lactone 9. 
 
3.1.2 Breuilles/Uguen Synthesis of Virginiamycin M2 
 
In 1998 Breuilles and Uguen, at the Universite Louis Pasteur, 
reported a synthesis of virginiamycin M2 (a.k.a. pristinamycin IIB) [32]. 
Their retrosynthetic strategy (Scheme 6) was similar to that of 
Schlessinger’s group; the target was dissected into a protected proline, 
a C3-C7 hydroxyenoate 29, a C9-C16 dienylamine (17), and a 2,4-
disubstituted oxazole 30. 
 
The C14 stereocenter inherent in the dienylamine segment 17 
was derived from dimethyl (S)-malate. Reduction to the butanetriol, 
followed by reaction with p-methoxybenzaldehyde gave the dioxalane 
31 (Scheme 7) [32a]. Moffat oxidation of 31 afforded a sensitive 
aldehyde 32 which was immediately reacted with excess ylide derived 
from bromomethyltriphenylphosphonium bromide to give a mixture of 
E- and Z-alkenylbromides 33. Elimination gave the alkyne 34 which 
was deprotected. Selective protection of the 1° alcohol of diol 35 
required considerable experimentation; eventually it was found that 
slow addition of the diol to PMB trichloroacetimidate and PPTS led to 
the monoprotected 36 (48%) along with unreacted 36 (23%) and 
diprotected diol (11%) all of which were separable by chromatography. 
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After protection of the remaining hydroxyl group, homologation was 
accomplished by deprotonation with n-butyl lithium and addition to 
paraformaldehyde. The 2° TMS ether was subsequently cleaved with 
HF⋅pyridine to afford the diol 37. Carbometallation of 37 with 
methylmagnesium chloride in the presence of 0.5 equivalents of CuI 
proceeded with modest regioselectivity to give an inseparable mixture 
of regioisomers 38a and 39a (1:3). Reaction of this mixture with 1.8 
equivalents of diphenyl-t-butoxysilyl chloride gave a separable mixture 
of disilylated 39b and monosilylated 38b. After separation, cleavage 
of the silyl protecting groups from 39b gave diol 40. A sequence of 
protection-deprotection steps gave 1° allylic alcohol 41 which was 
oxidized to the enal 42. From this point, completion of the C9-C16 
segment closely followed Schlessinger’s route (c.f. Scheme 3). 
Olefination gave 43 which upon C16 protecting group exchange and 
reduction of the nitrile gave dienylamine 17. The synthesis of 17 by 
Breuilles and Uguen is considerably longer (21 steps) than that by 
Schlessinger’s group. 
 
The Breuilles/Uguen preparation of the C3-C7 segment relies on 
the desymmetrization of the meso triol 44 (Scheme 8) [32b-d]. This 
triol was prepared on multi-gram scale by Reformatsky reaction of two 
equivalents of 2-bromopropanoic acid with ethyl formate to give 
diacid 45 as a mixture of diastereomers. Recrystallization of the 
mixture from ether gave the meso-syn,syn diastereomer 45a, which 
was converted into triol 44 by diazomethane esterification followed by 
reduction. Desymmetrization of the triol was accomplished by P . 
fluorescens lipase catalyzed acylation [32c]. Conversion of the 
remaining primary hydroxyl group of 46 into a thio ether followed by 
acetate hydrolysis gave the diol 47. The diol was then transformed 
into phenylsulfonate 48, which was subjected to Raney-Ni 
desulfurization to give the sulfone 49 which was protected as the PMB 
ether. Reaction of the anion derived from 50 with sodium iodoacetate, 
followed by diazomethane esterification and cleavage of the PMB 
protecting group afforded enoate 29 [32d]. 
 
Esterification of hydroxyenoate 29 with N-Boc-D-proline 
followed by removal of the N-Boc protecting group gave 51 (Scheme 
9). Coupling of this segment with 2-chloromethyloxazole-4-carboxylic 
acid gave the amide 52. Saponification of the enoate methyl ester, 
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followed by condensation with the C9- C16 dienylamine 17 afforded 
the diamide 53. Selective deprotection of the TBS ether, followed by 
iodide substitution and oxidation of the 1o alcohol gave 54 setting the 
stage for macrocyclization. To this end, reaction of 54 with a large 
excess of the chromous reagent prepared in situ from the reaction of 
CrCl3 with LiAlH4 resulted in formation of the C16-C17 bond to give 28, 
as a mixture of diastereomers, along with an unidentified de-iodinated 
product. Preparation of 2 8 constitutes a formal total synthesis of 
virginiamycin M2, since this compound was previously transformed into 
2 by Schlessinger and Li (see Scheme 5). This synthesis of 2 
proceeded in 28 steps (longest linear sequence); < 0.2% overall yield 
from (S)-butanetriol. 
 
3.1.3 Helquist Synthesis of the C9-C23 Segment 
 
Prior to the Schlessinger/Li or Breullies/Uguen total syntheses, 
Helquist’s group reported a synthesis of the C9-C23 diene segment 
[33] utilizing nucleophilic addition of an oxazolylmethane nucleophile 
to a dienal [31]. Their synthesis begins with free-radical bromination 
of ethyl 3-methyl-2- butenoate, followed by a Arbuzov reaction of the 
allylic halide with triethylphosphite to give the phosphonate ester 5 5 
(Scheme 10). 
 
Horner-Wadsworth-Emmons olefination of N-Bocglycinal 56 with 
55 gave predominantly the E,E-dienamine 57. The stereochemistry of 
the newly formed C10-C11 double bond is E- (>50:1) while the major 
stereochemistry of the C12-C13 double bond is also E- (10:1). 
Reduction of the ester group, followed by Swern oxidation gave the 
dienal 58. Asymmetric aldol condensation of 58 with lithium (S)-N -
acetyl-4- isopropyl-2-oxazolidinone [34] yielded two separable 
diastereoisomers 59a:59b (3:1 ratio, i.e. 50 % ee). The desired 
diastereoisomer (59a) was converted into the Weinreb’s amide and 
the free hydroxyl group protected as its silyl ether. Reduction of the 
Weinreb’s amide with DIBAL gave aldehyde 60. Reaction of the zinc 
functionalized species derived from 2- bromomethyl oxazole 61 [31] 
with 60 gave a mixture of diastereomeric alcohols which upon 
oxidation resulted in a single protected β-hydroxy ketone 62. 
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3.1.4 Brennan/Campagne Synthesis of C9-C22 Segment 
 
Brennan and Campagne have prepared a similar C9-C22 
segment of virginiamycin M2 [35]. The synthesis begins with a 
palladium-catalysed coupling of N-Boc propargylamine and methyl 2-
butynoate to yield 63 (Scheme 11). Reduction of the alkyne and the 
methyl ester was carried out by treating 63 with LiAlH4 to give the 
desired (E,E)-dienol 64. Swern oxidation of 64 yields aldehyde 65. An 
asymmetric acetoacetate vinylogous Mukaiyama-aldol reaction [36] of 
aldehyde 65 with the trimethylsilyloxydiene 66 in the presence of 
CuF(R)-TolBINAP followed by methanolysis of the TMS ether with PPTS 
yielded alcohol 67 (81% ee by chiral HPLC) which was protected as its 
MOM ether (68). Reaction of 68 with TBS protected serine methyl 
ester in toluene at elevated temperature gave amide 69, which was 
deprotected by treatment with HF-pyridine. The resulting amido 
alcohol was cyclized with diethylaminosulfurtrifluoride (DAST) [37] 
under basic condition to afford an oxazoline. Dehydrogenation of the 
oxazolidine using NiO2 proceeded in only 34% yield to give the oxazole 
70. 
 
3.1.5 Ahmed/Cao/Donaldson Synthesis of C9-C17 
 
Ahmed, Cao and Donaldson have prepared a C9-C17 segment of 
virginiamycin M2 [38a]. Their synthesis begins with the known [39] 
E,E-dienal-iron complex 71 (Scheme 12) . Reaction of 71 with 
benzylamine followed by NaBH4 reduction and protection gave the N-
Boc derivative 72. The ester complex was transformed into the triene 
73 by reduction, Saigo-Mukaiyama oxidation [40], and finally Peterson 
olefination. Cycloaddition of 73 with the nitrile oxide derived from 2-
(2-nitroethoxy)tetrahydropyran gave isoxazoline 74 as a mixture of 
diastereomers at the THP carbon. The diastereoselectivity of this 
cyclocondensation results from approach of the nitrile oxide to the 
complexed triene in the s-trans conformer on the face opposite to the 
bulky (tricarbonyl)iron group (Fig. 7). The s-trans conformer is the 
predominant conformer in solution due to destabilizing steric 
interactions in the s-cis conformer. Reductive hydrolysis of isoxazoline 
74 in the presence of commercially purchased Raney-Ni gave β-
hydroxyketone 75 as a mixture of diastereomers at the THP carbon. 
While the diastereoselectivity of the intermolecular nitrile oxide-olefin 
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cycloaddition was demonstrated on a racemic (triene)iron complex, 
preparation of the precursor (71) in optically active form would lead to 
an enantioselective synthesis [38b]. 
 
3.1.6 Helquist Route to the C3-C7 Segment of the 
Virginiamycins/Madumycins 
 
Helquist’s group has described a short route to the C3-C7 
segment 76 of the virginiamycins/madumycins [41]. This synthesis 
utilizes a diastereoselective aldol condensation between N-propionyl 
oxazolidinethione 77 and isobutyraldehyde to afford 78 (Scheme 13). 
Protection of the C3 alcohol, reductive removal of the chiral auxiliary, 
and olefination complete the synthesis. The Wittig olefination 
proceeded with 18:1 E:Z selectivity, and the two geometrical isomers 
could be separated by column chromatography. 
 
3.2 Synthesis of 14,15-Anhydropristinamycin IIB 
 
14,15-Anhydropristinamycin IIB (79, Scheme 14) is a 
streptogramin A antibiotic related to virginiamycin M2; the 
dehydroproline derivative has been isolated from S. olivaceus  
ATCC53527 [42]. Pattenden’s group has reported a total synthesis of 
79 which relies on a Stille-type Pd-catalyzed vinyltin coupling [43] 
strategy for closure of the macrocyclic ring. Their retrosynthetic 
analysis dissects the target molecule into a vinyl-tin amide segment 
80, a dienal bromide 81, and oxazole 82 (Scheme 14) [44]. 
 
Preparation of the vinyl-tin amide segment (C3-C11) begins 
with a diastereoselective aldol condensation between the N-propionyl 
oxazolidinone 83 [34] and isobutyraldehyde to afford 84 (Scheme 
15). Reductive removal of the chiral auxiliary with Red-Al, followed by 
Horner-Emmons olefination gave the unsaturated ester 85. Protection 
of the C3 alcohol, followed by amide formation with propargylamine 
gave 86. The MOM protecting group was removed and replaced by an 
acetyl group. Hydrostannylation of the propargyl amide gave the vinyl-
tin species 87. Saponification of the acetyl group gave the alcohol 80. 
 
Preparation of the C12-C16 dienal bromide 81 began with 
oxidation of the known allylic alcohol 88 to afford the enal 89 (Scheme 
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16). Horner-Emmons olefination, followed by reductive removal of the 
Weinreb’s amide gave 81. Reaction of the dianion generated from 4- 
hydroxymethylene-2-methyl-1,3- oxazole (82) with 81 gave the 
racemic dienol 90 in modest yield. Selective oxidation of the C23 
hydroxymethylene group in the presence of the C16 dienyl alcohol was 
accomplished using MnO2 to afford aldehyde 91. The authors propose 
that this selectivity may be due to prior association of the C16 dienyl 
hydroxyl group with the oxazole nitrogen which protects this group 
from reaction. Oxidation of the oxazole carboxaldehyde gives 
carboxylic acid 92. 
 
Coupling of the C3-C11 alcohol 80 with N-trifluoroacetyl D-
proline, followed by hydrolysis of the TFA group gave 93 (Scheme 17). 
Further coupling of carboxylic acid 92 with 93 gave the vinyl 
stannane-vinyl bromide acyclic precursor 94 as a mixture of 
diastereomers at C16. Palladium catalyzed intramolecular Stille 
coupling [43] of 94 with Pd2(dba)3 and triphenylarsine afforded the 
macrocyclic trienol 95, albeit in low yield. Oxidation of the alcohol 
completed the synthesis of anhydropristinamycin IIB. The synthesis 
proceeded in 14 steps, 1.3% overall yield from 83. 
 
3.3 Syntheses/Synthetic Studies of Madumycin IIB 
 
3.3.1 Meyers’ Synthesis of Madumycin II 
 
Meyers' group has reported a total synthesis of madumycin IIB 
[45]. Their strategy required dissecting 3 into two major components 
96 and 97 by disconnection at the two amide bonds (Scheme 18). 
 
Meyers route to the C9-C23 segment 96 began with 
transformation of (S)-malic acid into the Weinreb’s amide 98 by 1) 
Fischer esterification, 2) chelation controlled borane reduction, 3) 1,2-
diol protection, and 4) conversion to the amide (Scheme 19). Reaction 
of 98 with allyl magnesium bromide generated the β,γ-enone which 
underwent stereoselective reduction (>99% de) with LiAlH4 and LiI to 
afford the homoallylic alcohol 99. Protection of the secondary alcohol, 
ozonolysis and chlorate oxidation yielded the carboxylic acid 100. The 
carboxylic acid was converted into the requisite oxazole 101 by 1) 
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generation of the mixed anhydride with isobutylchloroformate, and 
amide formation with (S)-serine methyl ester, 2) cyclization to the 
oxazoline with Burgess reagent [46], and 3) oxidation of the oxazoline 
to oxazole with Cu(II)-Cu(I) peroxide reagent [47]. Deprotection of 
the C16 TBS ether followed by reaction with the dimethyl acetal of (2- 
mesityl)formaldehyde in the presence of a catalytic amount of 
camphorsulfonic acid gave the acetal 102. Swern oxidation of the 1° 
alcohol and Wittig olefination with α-formylethylidine 
triphenylphosphorane afforded the (E)-α,β-unsaturated aldehyde 103. 
Reaction of enal 103 with vinyl tributylphosphonium bromide and 
potassium phthalimide yielded the E,E-dienylamine, and removal of 
the methyl ester gave the oxazole carboxylic acid 96 (18 steps, 4.6 % 
overall yield). 
 
Meyers’ construction of the northern fragment of the macrolide 
utilized an Evans’ diastereoselective aldol condensation, similar to that 
reported by Pattenden (c.f. Scheme 15) to generate the alcohol 84. 
The acyl oxazolidinone 84 was converted into its corresponding 
Weinreb amide which was reduced to the aldehyde (Scheme 20). 
Olefination with diethyl 2-trimethylsilyl-ethyl phosphonoacetate gave 
104 as the pure (E)- isomer. The resulting alcohol was coupled with N-
Boc-Dalanine followed by toluenesulfonic acid mediated removal of the 
Boc protecting group afforded amino ester 97. 
 
Dicyclohexyl carbodiimide (DCC) mediated coupling of amine 97 
with acid 96 afforded the amide 105 in good yield (Scheme 21). 
Removal of the phthalimide protecting group was carried out by 
treating 105 with methylamine in ethanolbenzene mixture at 50ºC for 
2 days. Cleavage of the β-silylethylester was accomplished by treating 
with TBAF to yield 106. Finally coupling of the primary amine with the 
C7 carboxylic acid was carried out by treating 106 with i-Pr2EtN and 
bisoxazolidinone phosphoryl chloride (BOPCl) to yield 107. Hydrolysis 
of the acetal protecting group in 107 gave madumycin II (3) with 8-10 
% of a double bond isomer impurity. The Meyers synthesis requires 18 
steps for the preparation of diene fragment 96 from (S)-malic acid and 
an additional 5 steps to couple 97 with 96 to form 3. 
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3.3.2 Ghosh’s Synthesis of Madumycin II 
 
Ghosh’s group adopted a linear synthesis strategy to make 
madumycin II. Their retrosynthetic strategy dissected the molecule 
into a dienyl azide (108) and the unsaturated carboxylic acid (109) 
(Scheme 22) [48].  
 
Desymmetrization of the meso-cyclopentane-3,5-diacetate 110 
by enzymatic hydrolysis according to the procedure of Schefold [49], 
yielded alcohol 111 in 95% ee (Scheme 23). Protection of 111 
followed by ozonolysis and NaBH4 reduction gave the diol 112. 
Transesterification of the acetate with methanol and protection of the 
resultant 1,2-diol with 2,2-dimethoxypropane resulted in the formation 
of 113. Oxidation and olefination, in a fashion similar to that of Meyers 
(c.f. 102 –> 103, Scheme 19), gave the enal 114. Horner-Emmons 
olefination of 114 gave the E,E-dienoate 115. Transformation into the 
dienyl azide 116 was accomplished by reduction with DIBAL, 
generation of the mesylate and subsequent SN2 displacement with 
sodium azide. Selective removal of the acetonide in the presence of 
the MOM ether was accomplished by treatment with methanolic p-
TsOH. Mesylation of the 1º alcohol followed by SN2 displacement with 
cyanide gave nitrile 117 which was hydrolyzed to carboxylic acid 118. 
Treatment with BOP and diisopropylamine in the presence of silyl 
protected L-serine methyl ester gave the amide, which upon protection 
of the C16 hydroxyl group with MOMCl furnished 119. Conversion of 
119 to the oxazole 108 required 1) silyl ether deprotection with 
fluoride ion, 2) Burgess reagent [46] mediated cyclization to an 
oxazoline, and 3) oxidation to the oxazole by treatment with CuBr2, 
DBU, and HMTA [50]. 
 
Syn-homoallyl alcohol 120 was synthesised in >95% ee by 
reaction of the chiral (Z)-crotyl borane 121 [51] with isobutyraldehyde 
followed by oxidative workup (Scheme 24). The terminal vinyl group 
of 120 was subjected to ozonolytic cleavage and subsequent Horner-
Emmons olefination gave the α,β-unsaturated ester 85. The secondary 
alcohol was then protected as the THP ether, followed by 
saponification to give carboxylic acid 109. 
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Saponification of methyl ester 108 with aqueous LiOH followed 
by workup with dilute acid gave the corresponding carboxylic acid 
which was coupled with D-alanine methyl ester to afford 122 (Scheme 
25). Reduction of the azide functionality gave the primary amine 123. 
Amine segment 123 and acid segment 109 were joined by amide 
formation to afford 124. The THP protecting group was removed under 
acidic conditions followed by saponification of the C23 ester to afford 
125. Yamaguchi macrolactonization between the C2 hydroxyl group 
and the C23 carboxylic acid affords 126. Exposure of 126 to 
tetrabutylammonium bromide and an excess of dichlorodimethylsilane 
removes both of the MOM protecting groups of the 1,3-diol which 
concluded Ghosh’s synthesis of madumycin II (3). The Ghosh 
synthesis requires 19 steps for the preparation of diene segment 108 
from 3,5-diacetoxy cyclopentene and an additional 8 steps to complete 
the synthesis of 3 (0.68% overall yield). 
 
3.4 Syntheses/Synthetic Studies of Griseoviridin 
 
3.4.1 Meyers’ Synthesis 
 
Meyers' group has reported the only total synthesis of 
griseoviridin [52]. Their retrosynthetic strategy divided the molecule 5 
into a C11-C24 oxazole-diene 127 and the ninemembered vinyl sulfide 
macrolide 128 which would be joined using amide bond formation 
(Scheme 26).  
 
The preparation of diene segment began with the protected triol 
102, previously prepared from (S)-malic acid in the Meyers’ synthesis 
of madumycin IIB (c.f. Scheme 19) [47]. Oxidation of 102, followed 
by Wittig olefination with allyltriphenylphosphonium bromide gave 
diene 129 as a mixture of E- and Z-isomers (5:1, Scheme 27). 
Photolysis of this mixture in the presence of I2 gave exclusively the E-
isomer, which upon hydrolysis with LiOH gave the carboxylic acid 127. 
 
Condensation of the enolate anion from allyl acetate with 
(S)-3-t-butyldimethylsilyloxybutanal, followed by oxidation with Dess-
Martin periodinane gave the β-ketoester 130 (Scheme 28). Reaction 
of the anion of 130 with the electrophilic sulfur agent 131 proceeded 
with formation of the carbon-sulfur bond to give 132. The 
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configuration at this newly formed chiral center was irrelevant since 
reduction of the ketone functionality, mesylation of the resultant 
alcohol, and elimination gave the vinyl sulfide 133 (20:1, Z:E). 
Treatment of 133 with 10% HCl resulted in removal of both the TBS 
ether and hydrolysis of the t-butyl ester. Cyclization of the hydroxy 
acid 134 was accomplished under Mitsunobu conditions [53] to give 
the macrolide 1 3 5 with inversion at C5. The trichloroethoxycarbonyl 
protecting group was removed by reduction over Cd/Pb to afford the 
amino lactone 128. Many of these steps had been previously 
pioneered by Miller’s group (c.f. Scheme 32). 
 
Coupling of amino lactone 128 with the oxazole carboxylic acid 
127 gave the amide 136 (Scheme 29). Conversion of the allyl ester to 
the carboxylic acid under Pd-catalysis, followed by amide bond 
formation with allyl amine gave the cyclization precursor 137. 
Treatment of 137 with 30 mol % Grubbs’ “1st generation catalyst” 
[54] proceeded with formation of the macrolide 138 as a single olefin 
stereoisomer. Attempts to optimize the RCM conditions resulted in 
yields in the 37-42% range. Hydrolysis of the mesityl acetal gave 
griseoviridin (5). The Meyers synthesis requires 17 steps from (S)-
malic acid for the preparation of diene carboxylic acid 127 and an 
additional 5 steps to couple 127 with 128 to form 5. 
 
3.4.2 Ghosh/Lei Synthesis of C11-N26 Dienyloxazole Segment of 
Griseoviridin 
 
Ghosh and Lei have reported a synthesis of the C11-N26 
fragment (139, Scheme 30) of griseoviridin [55]. Allylation of 
benzyloxyacetaldehyde gives racemic alcohol 140 which upon lipase 
catalyzed acylation afforded a separable mixture of unreacted (S)-140 
and the optically active acetate (R)-141. Conversion (R)-141 into 
additional (S)-140 was accomplished by: i) saponification, ii) 
Mitsunobu inversion [53] with p-nitrobenzoic acid, and iii) 
saponification. Esterification of (S)-140 with acryloyl chloride and ring-
closing metathesis with Grubbs’ 1st generation catalyst in the presence 
of Ti(OiPr)4 [56] gave the unsaturated lactone 142. Epoxidation of 1 4 
2 proceeded in a diastereoselective fashion, and the resultant epoxide 
143 was reductively opened with diphenyldiselenide/NaBH4 in 
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isopropanol to afford the ester 144. Removal of the benzyl protecting 
group and selective protection of the 1,3-diol functionality gave 
145. The dienyl chain was installed by oxidation of the primary 
alcohol, Wittig olefination, addition of vinyl Grignard to the enal 146 
and acylation of the resultant secondary alcohol to afford acetate 147 
as a mixture of diastereomers. A palladium catalyzed dienyl acetate 
substitution with sodium azide gave 148 as the E,E-isomer. 
Conversion of the ester 148 into oxazole 139 was accomplished by a 
combination of methods used by Ghosh [48] and Meyers [45] in their 
syntheses of madumycin II (c.f. Schemes 19 and 22). The preparation 
of 139 requires 17 steps from benzyloxyacetaldehyde. 
 
3.4.3 Helquist Preparation of the Aminolactone Segment of 
Griseoviridin 
 
There are many synthetic studies reported for the aminolactone 
segment of griseoviridin. Helquist’s group reported a synthesis of the 
aminolactone segment in 1985 (Scheme 31) [57]. Aldol condensation 
of 1,3-oxathiolanone 149 with (S)-3-tetrahydropyranyloxy-butanal 
gave a mixture of diastereomeric alcohols 150. Mesylation followed by 
base mediated elimination gave 151 as a 2.5:1 mixture of E:Z 
isomers. Methanolysis of 151 gave the ester 152, exclusively as the 
Z-isomer. Reaction of the anion from 152 with the protected (S)-
iodomethyleneglycine 153 afforded the S-alkylation product 154. 
Hydrolysis of the THP ether as well as the diphenylmethyl ester, 
followed by Mitsunobu cyclization [53] gave the aminolactone 155. 
 
3.4.4 Miller’s Synthesis of a Diastereomeric Aminolactone 
 
Miller’s group reported a synthesis of an aminolactone 
diastereomeric at the C8 center with respect to griseoviridin (Scheme 
32) [58]. This difference in configuration is due to Miller’s use of the 
less expensive L-cystine as a starting material. Esterification as the t-
butyl ester and Cbz protection of the amino group gave 156. 
Treatment of the protected cystine with sulfuryl chloride followed by 
reaction with potassium phthalimide gave an electrophilic sulfur 
transfer agent 157. 
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Baker’s yeast mediated reduction of ethyl acetoacetate gave 
ethyl (S)-3-hydroxybutanoate [59]. Protection of the alcohol and 
saponification of the ester gave the carboxylic acid 158. Reaction of 
the carboxylic acid with carbonyldiimidazole and the magnesium salt of 
monomethyl malonate gave the β-keto ester 159. Reaction of the 
anion of 159 with the electrophilic sulfur agent 157, followed by 
ketone reduction, mesylation, and base mediated elimination afforded 
160. These steps were later utilized by Meyers’ group in their 
synthesis of the correct diastereomer of the aminolactone segment 
(c.f. Scheme 28). Hydrolysis of the TBS ether, followed by cleavage of 
the t-butyl ester and Mitsunobu cyclization [53] completed preparation 
of the diastereomeric aminolactone 161. 
 
3.4.5 Marcantoni/Bartoli Preparation of Aminolactone 
 
The groups of Marcantoni and Bartoli reported a synthesis of the 
aminolactone segment involving an aldol condensation between (S)-3-
MOMO-butanal (162) and an S-alkylated 2-thioacetate (163) (Scheme 
33) [60]. The aldehyde segment was prepared by Baker’s Yeast 
mediated reduction of ethyl acetoacetate [59]. In this case, the 
authors determined the enantiomeric excess to be 95.4% on the basis 
of Mischer’s ester technique [61]. Protection of the secondary alcohol 
and DIBAL reduction of the ester gave 162. Protection of D-cystine as 
its benzamide and t-butyl ester, followed by NaBH4 reduction of the 
disulfide bond gave the protected D-cysteine 164. Alkylation of 164 
with ethyl bromoacetate afforded 163. Generation of the magnesium 
anion of 163 and coupling with aldehyde 162 in the presence of CeCl3 
gave the alcohol 165 as a mixture of diastereomers. In this case, 
attempted mesylation/ elimination of 165, in a fashion similar to that 
pioneered by Miller, (Scheme 32) resulted in a “complex mixture of 
elimination products.” This difficulty was eventually overcome by use 
of CeCl3/NaI to give the vinylsulfide 166. These reaction conditions 
also effected hydrolysis of the MOM ether and t-butyl ester. Mitsunobu 
cyclization [53] of 166 gave the aminolactone 167. 
 
3.4.6 Ardisson’s Preparation of a Diastereomeric Aminolactone 
 
Ardisson’s group reported preparation of a diastereomeric 
aminolactone (Scheme 34) [62] similar to that reported by Miller. The 
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French group however utilized a unique strategy compared to those 
outlined above. Reaction of (S)-propylene oxide with lithium acetylide 
gave (S)-1-pentyn-4-ol, which was protected as its triethysilyl ether 
(168). Deprotonation of 168 and reaction with the electrophilic sulfur 
agent 169, derived from L-cystine, gave the alkynyl sulfide 170. 
Removal of the TES protecting group, saponification of the methyl 
ester and Mitsunobu cyclization [53] gave the alkynyl lactone 171. 
The requisite ester functionality was introduced by Pd-catalyzed 
hydrostannylation of 171, followed by tin-halogen exchange to afford 
the vinyl iodide 172. A Pd-catalyzed methoxycarbonylation completed 
the synthesis of the diastereomeric aminolactone segment 173. 
 
3.4.7 Ardisson’s Second Generation Approach to the 
Aminolactone Segment 
 
More recently, Ardisson’s group reported a very short, albeit 
non-stereoselective and lower yielding, approach to the aminolactone 
segment of griseoviridin (Scheme 35) [63]. Reaction of (S)-propylene 
oxide with the anion derived from lithio ethyl propynoate gave alkynol 
174. Esterification of bis-N-Boc L-cystine with 174 afforded 175; 
notably, both chiral centers are opposite in configuration to that 
required for naturally occurring griseoviridin. Zinc/acetic acid mediated 
reduction of the disulfide bond of 175 and work-up with silver nitrate 
gave the diastereomeric aminolactones (8R)-176 and (8S)-176 which 
were separable by column chromatography. Presumably, reduction of 
175 proceeds with epimerization at the C8. 
 
4. Conclusion 
 
The streptogramin A macrolides are effective antibiotics, 
particularly when combined with the streptogramin B cyclic 
polypeptides. These agents act to halt protein synthesis against 
Gram-positive bacteria by binding to the 50S or 70S ribosomes. The 
complex structure of the streptogramin A antibiotics combined with 
their impressive biological activity has generated considerable 
synthetic interest, culminating in total syntheses of virginiamycin M2 
(2), madumycin IIB (3), 14,15- anhydropristinamycin (81), and 
griseoviridin (5). Additionally, due to the wide variety of chemical 
functionality present in these molecules, these synthetic studies have 
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resulted in the development of methodology which can be applicable to 
a wide variety of naturally occurring targets. 
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